
Betalin Therapeutics won second prize at the Chinese IPIEC Global 2017 competition receiving $100K award
Xi’an International Entrepreneurship Competition (abbreviated as “XIEC”) is a Chinese annual international innovation and entrepreneurship conference for cooperation and communication through international competitions. The competitions are

Israeli Ministry of Foreign Affairs diplomatic corps cadets get a taste of the Jerusalem Bio and Life Science Innovation scene
March5, 2018 – The Israeli Ministry of Foreign Affairs cadets were given an overview of the Jerusalem Bio and Life Science Innovation scene by JLM-BioCity. The event was

Teva Plant in JLM is the Right Facility to become a CDMO, this is a win-win situation for Teva and Contract Manufacturers to save an excellent crew with an excellent site.
Teva is downsizing and shedding some of its manufacturing facilities here in Israel, including two of its manufacturing facilities in Jerusalem. One of these facilities

Jlm-Based Orcam Raised $ 30.4 Million at a Value of $ 1 Billion
February 20, 2018 – $1.01B: Jerusalem -based computer vision startup OrCam Technologies, which has developed a visual aid for the blind, became the latest company to make

Alynnovation is Open for Entrepreneurs in Assistive Technologies for Children
March 7, 2018 ALYN Hospital has opened ALYNnovation, a commercial track that partners with entrepreneurs and inventors in developing and commercializing assistive technology products and solutions for children on a global scale

Granalix’s Pomegranate Extract is an Israeli Supplement for Preventing and Improving Neurodegenerative Diseases
February 26, 2018 – Pomegranates are known to contain powerful antioxidants that fight the oxygen free radicals that cause inflammation, accelerated aging of the tissues,

Ran Poliakine’s New Innovation Center is Now Open for Applications
Feb 8, 2018 – Ran Poliakine of Nveh Ilan hase just announced the launch of a brand-new innovation center that intends to focus on early-stage ventures in

Prof. David Naor’s Drug Could Treat Alzheimer’s, MS, Crohn’s and More
February 11,2018 Prof. David Naor, from the Lautenberg Center for General and Tumor Immunology at the Hebrew University-Hadassah Medical School, Jerusalem, believes that all these diseases, which
BioCanCell Announces Updated Results from the Phase II Clinical Trial of BC-819 and BCG in Patients With Bladder Cancer
Nov. 15, 2017 (GLOBE NEWSWIRE) — BioCancell Therapeutics (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat